Filter
684
Filtered Results: 684
Text search:
Hwang,
J.
Featured
Recommendations
66
New Publications
81
Language
Document type
No document type
244
Studies & Reports
187
Guidelines
145
Manuals
37
Fact sheets
36
Strategic & Response Plan
18
Training Material
10
Infographics
4
Situation Updates
3
Countries / Regions
Global
32
Brazil
21
Russia
21
India
17
Germany
14
Western and Central Europe
14
Latin America and the Carribbean
13
South Africa
13
Middle East and North Africa
10
Syria
8
Africa
8
Asia
8
Kenya
7
Ghana
7
Nigeria
7
Ethiopia
7
Indonesia
7
China
6
Mozambique
6
West and Central Africa
6
Eastern Europe and Central Asia
6
Bangladesh
6
Vietnam
6
Liberia
6
Colombia
5
Sierra Leone
5
Peru
5
Philippines
5
Spain
5
Eastern Europe
5
Yemen
5
Angola
5
Ecuador
5
Ukraine
4
Cambodia
4
South–East Asia Region
4
East and Southern Africa
4
Myanmar / Burma
4
Burkina Faso
3
Guinea-Bissau
3
Congo, Democratic Republic of
3
Argentina
3
Uganda
3
Thailand
2
Rwanda
2
Laos
2
Malawi
2
Western Pacific Region
2
Jamaica
2
France
2
Portugal
2
Bolivia
2
South Sudan
2
North Macedonia
1
Nepal
1
Switzerland
1
Benin
1
Togo
1
Chile
1
Cameroon
1
Canada
1
Zimbabwe
1
Austria
1
Mongolia
1
Guinea
1
Italy
1
Armenia
1
Haiti
1
Venezuela
1
Tanzania
1
Jordan
1
Belgium
1
United Kingdom
1
Belarus
1
Israel
1
Sri Lanka
1
Namibia
1
Sudan
1
Georgia
1
Mali
1
Zambia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
203
Clinical Guidelines
55
Public Health
47
Women & Child Health
17
Key Resources
13
Capacity Building
8
Pharmacy & Technologies
5
Toolboxes
COVID-19
183
Mental Health
82
HIV
53
Planetary Health
49
TB
36
NTDs
31
NCDs
22
Disability
18
AMR
18
Caregiver
17
Rapid Response
13
Health Financing Toolbox
12
Ebola & Marburg
10
Pharmacy
7
Zika
7
Global Health Education
6
Refugee
5
Natural Hazards
4
Cholera
3
Conflict
3
Social Ethics
2
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
BackgroundClimate change is one of the great challenges of our time. The consequences of climate change on exposed biological subjects, as well as on vulnerable societies, are a concern for the entire scientific community. Rising temperatures, heat waves, floods, tornadoes, hurricanes, droughts, fir...
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Consensual Recommendation for treatment of COVID-19 in older adults
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
La 3ieme édition du nouveau mini-manuel.
Au cours des mois à venir COVID Reference publiera des mises à jour régulières.
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
